FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Labetalol Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 03/01/2017
»Therapeutic Categories: Cardiovascular

Expand all

Akorn Pharmaceuticals (Revised 10/12/2017)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg/mL (100mg/20mL) Multi-Dose vial (NDC 17478-420-20) Available Other
5mg/mL (200mg/40mL) Multi-Dose vial (NDC 17478-420-40 ) Available Other

Hospira, Inc. (Revised 07/20/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg/20 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2267-20) Limited Supply Available. Next Delivery and Estimated Recovery: October 2018 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
200 mg/40 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2267-54) Next Delivery: August 2018; Estimated Recovery: December 2018 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
20 mg/4 mL (5 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2339-34) Next Delivery: July 2018; Estimated Recovery: March 2019 Shortage per Manufacturer: Manufacturing Delay

Dear Health Care Provider

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English